@alnylampharmaceuticals Alnylam Pharmaceuticals

Alnylam Pharmaceuticals posts on YouTube about $alny, rare, rna, science the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

[--] Week [---] -18%
[--] Month [-----] -0.59%
[--] Months [------] -8.20%
[--] Year [------] +168%

Mentions: [--] #

Mentions Line Chart

[--] Months [--] -42%
[--] Year [--] +416%

Followers: [-----] #

Followers Line Chart

[--] Week [-----] no change
[--] Month [-----] +1.10%
[--] Months [-----] +5.20%
[--] Year [-----] +11%

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence countries stocks finance

Social topic influence $alny #12, rare, rna, science, in the, testing, gene #229, journey, biotech, pharma

Top assets mentioned Alnylam Pharmaceuticals, Inc. (ALNY) Frontline Ltd. (FRO)

Top Social Posts

Top posts by engagements in the last [--] hours

"Alnylam's siRELIS(TM) Enzymatic Ligation Platform This video is intended for U.S. audiences. This video explains how Alnylam's siRELIS(TM) Enzymatic Ligation Platform is poised to transform oligonucleotide manufacturing and to help Alnylam meet the growing global demand for RNAi therapeutics. Learn more about how we make our medicines: https://www.alnylam.com/our-science/making-our-medicines ALNY-EL-2025-1"
YouTube Link 2025-12-17T18:36Z [----] followers, [---] engagements

"Alnylam & RNAi Therapeutics: Making our Medicines This video is intended for U.S. audiences. Alnylam has pioneered RNAi therapeutics an innovative class of medicines that uses small interfering RNA (siRNA) to silence the genes that cause or contiribute to disease. But how are these complex medicines made Alnylam's manufacturing team figured out how to make these medicines at scale something no one had ever done before. Our work is ensuring that RNAi (RNA interference) therapeutics can be made in quantities to benefit as many patients who may benefit from them as possible. ALNYMoM2025-2 #RNAi"
YouTube Link 2025-09-30T18:52Z [----] followers, [---] engagements

"Get to Know Alnylam - The Leader in RNAi Therapeutics Alnylam has pioneered RNAi (RNA interference) therapeutics - an innovative class of medicines which silences the genes that cause or contribute to disease. We're a global and fast growing biopharmaceutical company driven to have a positive impact on the lives of people around the world both with our medicines and our actions outside of the lab. We invite you to learn more at alnylam.com ALN-CORP-OVV-JAN24 Alnylam Alnylam Pharmaceuticals RNAi RNAi Therapeutics Biotechnology siRNA Alnylam Alnylam Pharmaceuticals RNAi RNAi Therapeutics"
YouTube Link 2024-01-05T16:54Z [----] followers, [----] engagements

"Diagnosing AHP This video was created for U.S. audiences. A panel of multidisciplinary physicians discuss the difficulties of recognizing symptoms associated with acute hepatic porphyria (AHP) as well as the commonly used methods involved in testing for and confirming a diagnosis of AHP. Visit www.PorphyriaDiagnosis.com for more information. AS1-USA-00265"
YouTube Link 2020-11-23T22:48Z [----] followers, [----] engagements

"Treating and Managing Patients with AHP This video was created for U.S. audiences. A panel of multidisciplinary physicians discuss their approaches to managing the care of acute hepatic porphyria (AHP) patients. Visit www.PorphyriaDiagnosis.com for more information. AS1-USA-00267"
YouTube Link 2020-11-23T22:48Z [----] followers, [---] engagements

"Sophia's experience with genetic testing This video was created for audiences in the UK. Sophia explains how she found out she has hATTR amyloidosis and her desire to advocate for others. NP-UK-00119"
YouTube Link 2023-02-23T13:17Z [----] followers, [----] engagements

"Sue - Living with Acute Hepatic Porphyria (AHP) This video was created for CEMEA audiences. Acute Hepatic Porphyria (AHP) is a chronic disease that can place a heavy burden on the lives of patients and their loved ones. Hear from Sue how she was diagnosed with acute hepatic porphyria how she copes with it and how it affects her daily live. "Im advocating to try and make sure theres a lot of awareness disease awareness. To make sure that my little girl doesnt suffer in the same way that me and my sister have. Because no one should suffer in the way that we have." AS1-CEMEA-00103 Alnylam"
YouTube Link 2020-10-05T21:35Z [----] followers, [----] engagements

"John living with Hereditary ATTR (hATTR) amyloidosis This video was created for audiences in the UK & Ireland. In Scotland John is living with Hereditary ATTR (hATTR) amyloidosis - an inherited progressive disease caused by a genetic mutation that results in the misfolding of transthyretin (TTR) proteins. He and his wife Rosemary discuss their family their journey to diagnosis and their hopes and fears for the future. NP-UK-00098 Alnylam Alnylam pharmaceuticals ALNY $Alny hATTR amyloidosis hereditary ATTR hATTR hereditary ATTR amyloidosis amyloidosis RNAi RNAi therapeutics rare disease rare"
YouTube Link 2022-05-03T17:58Z [----] followers, [----] engagements

"Alnylam Challengers: Improving Access to Healthcare in Boston by Investing in Care Navigators This video is intended for U.S. audiences. In Boston life expectancy can differ by up to [--] years between neighborhoods located just miles apart. To help address this weve invested $2 million through our Alnylam Challengers program to support frontline Care Navigators who help the hardest to reach patients in underserved communities access vital social and medical services. Visit Alnylam.com to learn more: https://bit.ly/4oSlHBt ALNY-CH-2025-1"
YouTube Link 2025-11-19T13:13Z [----] followers, [---] engagements

"Alnylam Act - No Charge Third Party Genetic Testing & Counseling Learn about Alnylam Act Alnylams no charge third party genetic testing and counseling service for individuals who may carry gene mutations known to be associated with either hereditary ATTR (hATTR) amyloidosis acute hepatic porphyria (AHP) or primary hyperoxaluria type [--] (PH1). Get more information at AlnylamAct.com. Genetic testing is available in the U.S. and Canada and genetic counseling is only available in the U.S. and certain other countries. NP-USA-00942"
YouTube Link 2025-06-17T01:10Z [----] followers, [---] engagements

"Alicia - Living with Acute Hepatic Porphyria (AHP) This video was created for CEMEA audiences. Acute Hepatic Porphyria (AHP) is a chronic disease that can place a heavy burden on the lives of patients and their loved ones. Hear from Alicia how she was diagnosed with acute hepatic porphyria how she copes with it and how it affects her daily live. "So youve always got to take every day as it comes and hope that youll get through the attack with your friends your family the medication the doctors so you can carry on and have a future." AS1-INTR-00021 Alnylam Alnylam pharmaceuticals alnylam"
YouTube Link 2024-10-21T15:51Z [----] followers, [---] engagements

"What is RNAi and How Do RNAi-based Medicines Work Medicines based on RNA interference (RNAi) work by silencing or disabling the production (expression) of the genes that cause specific diseases.The discovery of RNAi was awarded the [----] Nobel Prize in Physiology or Medicine. Alnylam has been working since [----] to pioneer RNAi-based medicines called RNAi therapeutics and bring them to patients as an innovative new class of medicines. Our approved medicines (the world's only approved RNAi therapeutics) and deep pipeline of investigational medicines have been developed to treat a host of human"
YouTube Link 2020-05-11T19:18Z [----] followers, 19.3K engagements

"Alnylam Announces $250 Million Expansion of U.S. RNAi Therapeutics Manufacturing Facility This video is intended for U.S. audiences On December [--] [----] Alnylam announced a $250 million expansion of our Norton Massachusetts (USA) drug manufacturing facility. This investment reflects our commitment to ongoing innovation and the Massachusetts life-sciences ecosystem and will help ensure that RNAi-based medicines will be produced here at scale for the benefit of patients world-wide. Learn more about this investment: https://bit.ly/4jdQXsz and we invite you to learn more about how we make our RNAi"
YouTube Link 2025-12-22T17:31Z [----] followers, [---] engagements

"hATTR amyloidosis: Know Your Family History This video was created for U.S. audiences. Angel's family lived with a rare life-threatening condition they called "the curse" for generations. The condition called hereditary ATTR (hATTR) amyloidosis was first accurately diagnosed in her grandfather and great uncles in the 1980s. Her mother's generation is now battling the condition but they now know how to recognize the symptoms and better manage them. Learn more about hATTR amyloidosis and the importance of knowing your family history at https://www.hattrbridge.com/ TTR02-USA-00045-012018"
YouTube Link 2020-08-10T16:51Z [----] followers, [---] engagements

"Helping Hands - Community Service Day [----] Alnylam employees invested more than [----] hours of service to [--] local organizations across the world during our 5th annual Helping Hands Community Service Day. Our CSD is an important part of our commitment to our people and the communities in which we work and live. Learn more about our culture at https://www.alnylam.com/careers/our-culture/"
YouTube Link 2020-07-13T18:00Z [----] followers, [---] engagements

"Nathan - Living with Hereditary Coproporphyria (HCP) This video was created for U.S. audiences. Nathan is living with hereditary coproporphyria (HCP) a type of acute hepatic porphyria (AHP). In this video he shares his experience living with this rare disease. AHP refers to a family of rare genetic diseases characterized by potentially life-threatening attacks and for many patients chronic debilitating symptoms that negatively impact daily functioning and quality of life. Learn more: www.PinpointAHP.com AS1-USA-00401"
YouTube Link 2020-04-14T19:20Z [----] followers, [----] engagements

"David living with Hereditary ATTR (hATTR) amyloidosis This video was created for UK audiences. David from the UK is living with Hereditary ATTR (hATTR) amyloidosis - an inherited progressive disease caused by a genetic mutation that results in the misfolding of transthyretin (TTR) proteins. He and his wife Sue discuss the moment of diagnosis. NP-IRL-00006"
YouTube Link 2021-10-27T22:42Z [----] followers, [----] engagements

"Tsuyoshi's Story - (TTR-FAP) TTR-FAP TTR-FAPthe BRIDGE https://hattrbridge.jp TTR-JPN-00057 Alnylam AlnylamJapan Amyloidosis TTR ATTR hATTR Alnylam Japan Japanese TTR Patients TTR Patient hATTR Bridge hATTRBridge Alnylam AlnylamJapan Amyloidosis TTR ATTR hATTR Alnylam Japan Japanese TTR Patients TTR Patient hATTR Bridge hATTRBridge"
YouTube Link 2024-10-24T20:07Z [----] followers, [----] engagements

"Hannahs Story - Living with hATTR Amyloidosis This video was created for U.S. audiences. Hannah talks about being diagnosed with hereditary ATTR (hATTR) amyloidosis and shares her experience with others interested in learning more about this condition. hATTR amyloidosis is a rare inherited disease caused by a genetic variant or change in the transthyretin (TTR) gene. This change in the TTR gene may also be referred to as a mutation. hATTR amyloidosis affects approximately [-----] people worldwide. Many people remain undiagnosed or misdiagnosed. Learn more at https://hattrbridge.com/."
YouTube Link 2022-09-09T19:27Z [----] followers, [----] engagements

"Cece - Reflecting on Life with hATTR Amyloidosis This video was created for U.S. audiences. Cece talks about being diagnosed with hATTR amyloidosis and shares some wisdom with others who may learn they have this condition. Hereditary ATTR (hATTR) amyloidosis is an inherited progressive disease caused by a genetic mutation that results in the misfolding of transthyretin (TTR) proteins. This results in the formation of amyloid fibrils that could deposit in the nerves heart and/or gastrointestinal (GI) tract. hATTR amyloidosis affects approximately [-----] people worldwide. Many people remain"
YouTube Link 2020-06-18T01:50Z [----] followers, [---] engagements

"hATTR amyloidosis: The Importance of Genetic Testing This video was created for U.S. audiences. A family living with hATTR amyloidosis discusses the importance of genetic testing to them. Alnylam sponsors third-party genetic testing and counseling services in certain countries at no charge through Alnylam Act. For more information about Alnylam Act and hATTR amyloidosis please visit https://www.hattrbridge.com/seeking-a-diagnosis TTR02-USA-00046"
YouTube Link 2020-08-10T16:16Z [----] followers, [---] engagements

"Sue - Living with Acute Hepatic Porphyria (AHP) This video was created for CEMEA audiences. Acute Hepatic Porphyria (AHP) is a chronic disease that can place a heavy burden on the lives of patients and their loved ones. Hear from Sue how she was diagnosed with acute hepatic porphyria how she copes with it and how it affects her daily live. "Im advocating to try and make sure theres a lot of awareness disease awareness. To make sure that my little girl doesnt suffer in the same way that me and my sister have. Because no one should suffer in the way that we have." AS1-INTR-00020 Alnylam alnylam"
YouTube Link 2024-10-21T15:51Z [----] followers, [---] engagements

"Alnylam Act - No Charge Third Party Genetic Testing & Counseling This video was created for U.S. audiences. Learn about Alnylam Act Alnylams no charge third party genetic testing and counseling service for individuals who may carry gene mutations known to be associated with either hereditary ATTR (hATTR) amyloidosis acute hepatic porphyria (AHP) or primary hyperoxaluria type [--] (PH1). Get more information at AlnylamAct.com. Genetic testing is available in the U.S. and Canada and genetic counseling is only available in the U.S. and certain other countries. NP-USA-00001"
YouTube Link 2022-02-24T20:19Z [----] followers, [---] engagements

"PH1 of a Kind - Ashas Story: Learning About Doctors Visits This video was created for U.S. audiences. Watch as Asha from Egypt learns about why frequent doctors visits are necessary when you have PH1 and comes to understand how theyre part of helping keep her as strong and healthy as possible. Primary hyperoxaluria type [--] is a rare genetic disease. PH1 of a Kind has been developed in partnership with the Oxalosis & Hyperoxaluria Foundation. PH1 of a Kind is a 4-part video series starring Isabelle Luuk Asha and Will* kids from around the world who have been diagnosed with PH1. Having this rare"
YouTube Link 2019-11-04T16:28Z [----] followers, [---] engagements

"hATTR amyloidosis: Know Your Family History This video was created for U.S. audiences. Angel's family lived with a rare life-threatening condition they called "the curse" for generations. The condition called hereditary ATTR (hATTR) amyloidosis was first accurately diagnosed in her grandfather and great uncles in the 1980s. Her mother's generation is now battling the condition but they now know how to recognize the symptoms and better manage them. Learn more about hATTR amyloidosis and the importance of knowing your family history at https://www.hattrbridge.com/ TTR02-USA-00046-012018"
YouTube Link 2022-02-24T20:19Z [----] followers, [---] engagements

"hATTR amyloidosis: The Family Dynamic This video was created for U.S. audiences. A family living with hATTR amyloidosis discusses the hereditary aspect of the condition and how it has affected them. You can be your family's most valuable resource for learning about hATTR amyloidosis. Learn more at https://hattrbridge.com/. TTR02-USA-00045"
YouTube Link 2020-06-18T01:21Z [----] followers, [----] engagements

"One familys journey with hereditary TTR amyloidosis: Dan and Diana This video was created for audiences in Canada. Siblings living with hATTR in Canada Dan and Diana talk about their journey to diagnosis the importance of genetic testing and their support for each other. The video also includes input from their physician who talks about the benefits of diagnosing hATTR as early as possible to improve outcomes. TTR-CAN-00020"
YouTube Link 2023-03-24T16:36Z [----] followers, [----] engagements

"Caregiver Perspectives: Jackie and Colin Primary Hyperoxaluria Type [--] (PH1) This video was created for CEMEA audiences. As a newborn Ziggy was diagnosed with primary hyperoxaluria type [--] (PH1)a rare inherited disease that causes the overproduction of oxalate which builds up as crystals throughout the body. Watch Ziggys parents Jackie and Colin discuss their familys experience navigating life with PH1. NP-UK-00439"
YouTube Link 2025-03-11T16:39Z [----] followers, [---] engagements

"About hATTR Tipping Point (U.S.) This video was created for US audiences. Hereditary transthyretin-mediated (hATTR) amyloidosis is a rapidly progressive genetic condition that affects several parts of the body including the nerves heart and gastrointestinal (GI) tract. The symptoms of hATTR amyloidosis can vary widely and may be similar to those of more common conditions resulting in misdiagnosis or delays in diagnosis. In this video youll see some of the seemingly random symptoms and confusion that patients with hATTR amyloidosis experienced before reaching their tipping point and working"
YouTube Link 2022-08-09T17:31Z [----] followers, [---] engagements

"International Porphyria Awareness Week PAG Perspectives: Australia This video was created for US audiences. Jessica Betterridge from the Australian Porphyria Association discusses the importance of raising awareness of porphyria a rare often genetic disease and how the community can get involved in International Porphyria Awareness Week. For more information on porphyria visit https://www.gpac-porphyria.org/ AS1-USA-00970"
YouTube Link 2021-04-02T17:45Z [----] followers, [---] engagements

"hATTR amyloidosis: Become a Family Advocate This video was created for U.S. audiences. Although she tested negative for the gene mutation that causes hereditary ATTR (hATTR) amyloidosis Angel stepped up as an advocate and caregiver for her family. Today she continues to promote awareness of the condition and its debilitating effects. Learn more about being an advocate and resource for your family at https://www.hattrbridge.com/. TR02-USA-00044-012018"
YouTube Link 2020-08-10T16:45Z [----] followers, [---] engagements

"hATTR amyloidosis: The Journey to Diagnosis This video was created for U.S. audiences. A family living with hATTR amyloidosis talks about some of the symptoms its members experience and the importance of educating themselves and their healthcare professionals. Symptoms of hATTR amyloidosis may be similar to those of other conditions. Learn about your family health history to help facilitate a conversation with your healthcare professional. Learn more at https://hattrbridge.com/. TTR02-USA-00044"
YouTube Link 2020-08-10T16:05Z [----] followers, [----] engagements

"RNAi Therapeutics - How this New Class of Medicines Works This video was created for U.S. audiences. Alnylam is the world's leading RNA interference (RNAi) company and has pioneered the [----] Nobel Prize-winning discovery of RNAi into an innovative new class of medicines. RNAi therapeutics work by silencing or disabling the production (expression) of the genes that cause specific diseases. In doing so RNAi therapeutics work upstream of most other classes of medicines such as small molecules and monoclonal antibodies by targeting the root genetic cause of a disease rather than its symptoms."
YouTube Link 2022-09-15T14:34Z [----] followers, 18.9K engagements

"Rosaline living with Hereditary ATTR (hATTR) amyloidosis This video was created for audiences in Ireland. Rosaline from Ireland is living with Hereditary ATTR (hATTR) amyloidosis an inherited progressive disease caused by a genetic mutation that results in the misfolding of transthyretin (TTR) proteins. She discusses the impact of hATTR on her family her life before her diagnosis and how she is living with the disease now. TTR02-UKI-00171"
YouTube Link 2021-08-02T17:31Z [----] followers, [----] engagements

"hATTR Tipping Point Jean (U.S.) This video was created for U.S. audiences. Meet Jean living with hereditary transthyretin-mediated (hATTR) amyloidosis. As her symptoms began to worsen over time Jean wasn't sure how or if they all fit together. Eventually after falling at a restaurant Jean reached her tipping point and knew she needed answers. Learn more about hATTR amyloidosis at http://www.hATTRbridge.com. TTR-USA-00088"
YouTube Link 2022-11-08T17:26Z [----] followers, [---] engagements

"hATTR amyloidosis: Explore Genetic Testing This video was created for U.S. audiences. Angel's family sought genetic testing and counseling to understand their risk for hereditary ATTR (hATTR) amyloidosis and the implications of a diagnosis. If you're interested in knowing if you or a loved one may carry a mutation in the TTR gene associated with hATTR amyloidosis learn more about genetic testing on hATTRBridge.com and one option for genetic testing Alnylam Act a no charge third-party genetic testing and counseling program sponsored by Alnylam. TR02-USA-00046-012018"
YouTube Link 2020-08-10T16:38Z [----] followers, [---] engagements

"RNAi Therapeutics - How this New Class of Medicines Works This video was created for UK and Irish audiences. Alnylam is the world's leading RNA interference (RNAi) company and has pioneered the [----] Nobel Prize-winning discovery of RNAi into an innovative new class of medicines. RNAi therapeutics work by silencing or disabling the production (expression) of the genes that cause specific diseases. In doing so RNAi therapeutics work upstream of most other classes of medicines such as small molecules and monoclonal antibodies by targeting the root genetic cause of a disease rather than its"
YouTube Link 2021-08-02T17:35Z [----] followers, 10.8K engagements

"Caregiver Perspectives: Jackie and Colin Primary Hyperoxaluria Type [--] (PH1) This video was created for CEMEA audiences. As a newborn Ziggy was diagnosed with primary hyperoxaluria type [--] (PH1)a rare inherited disease that causes the overproduction of oxalate which builds up as crystals throughout the body. Watch Ziggys parents Jackie and Colin discuss their familys experience navigating life with PH1. NP-INTX-00176 Alnylam Alnylam pharma alnylam pharmaceuticals PH1 primary hyperoxaluria primary hyperoxaluria type [--] patient story patient journey with ph1 caregiver caregiver story PH1 caregiver"
YouTube Link 2025-04-17T17:53Z [----] followers, [---] engagements

"The Skinner Family - Living with Primary Hyperoxaluria Type [--] (PH1) This video was created for US audiences. Three of the four Skinner children have been diagnosed with PH1 a rare life-threatening disease that can cause irreparable damage to kidneys and other vital organs. Learn more about PH1 by visiting TakeOnPH1.com. PH1-USA-00106"
YouTube Link 2022-03-16T17:12Z [----] followers, [---] engagements

"International Porphyria Awareness Week PAG Perspectives: Canada This video was created for Canadian audiences. Wendy Sauv from the Canadian Association for Porphyria/ Associacin Canadienne de Porphyrie discusses the importance of raising awareness of porphyria a rare often genetic disease and how the community can get involved in International Porphyria Awareness Week. For more information on porphyria visit https://www.gpac-porphyria.org/ AS1-USA-00964"
YouTube Link 2021-04-02T17:45Z [----] followers, [---] engagements

"Ania (UK) - Living with Acute Intermittent Porphyria This video was created for UK audiences. Ania from the UK is living with acute intermittent porphyria (AIP). In this video she shares her story and thoughts about living with this rare disease. Porphyria is a family of rare genetic diseases characterized by potentially life-threatening attacks and for some patients chronic debilitating symptoms that negatively impact daily functioning and quality of life. Porphyria includes eight subtypes and each has unique manifestations making an accurate diagnosis even more challenging. Four of these"
YouTube Link 2019-02-28T03:35Z [----] followers, 23.3K engagements

"RNAi "RNA interference (RNAi)1 RNAiRNAiAlnylam()RNAismall interfering RNA(siRNA)RNAiRNA(mRNA) https://www.alnylam.jp/our-science"
YouTube Link 2023-03-23T13:54Z [----] followers, [----] engagements

"Acute Hepatic Porphyria: What happens in the body This video was created for U.S. audiences. Acute Hepatic Porphyria (AHP) is a family of rare genetic diseases that many people probably have never heard of let alone know how it works in the body. AHP is characterized by potentially life-threatening attacks and for some people chronic debilitating symptoms that negatively impact daily functioning and quality of life. Take a look at this short video to learn more about how AHP affects the body its signs and symptoms and common misdiagnoses. Talk to your doctor for more information about AHP and"
YouTube Link 2020-04-17T19:52Z [----] followers, 20.6K engagements

"RNA de interferncia (RNAi) - Momento Eureka This video was created for Brazilian audiences. Saiba mais: https://www.alnylam.com/alnylam-brazil/"
YouTube Link 2019-04-30T16:50Z [----] followers, 29K engagements

"Chen (Brazil) Living with hATTR Amyloidosis This video was created for U.S. audiences. Chen from Brazil lives with hereditary ATTR (hATTR) amyloidosis. He discusses how the side effects of this rare disease have impacted him and shares his determination to live life to the fullest despite them. Hereditary ATTR (hATTR) amyloidosis is an inherited progressive disease caused by a genetic mutation that results in the misfolding of transthyretin (TTR) proteins. This results in the formation of amyloid fibrils that could deposit in the nerves heart and/or gastrointestinal (GI) tract. hATTR"
YouTube Link 2021-10-27T22:46Z [----] followers, [----] engagements

"PH1 of a Kind - Luuks Story: Learning to Stay Positive This video was created for U.S. audiences. Watch as Luuk and older brother Sem from the Netherlands talk about life with PH1 while Sem helps Luuk understand why he is not alone and should feel hopeful. Primary hyperoxaluria type [--] is a rare genetic disease. PH1 of a Kind has been developed in partnership with the Oxalosis & Hyperoxaluria Foundation. PH1 of a Kind is a 4-part video series starring Isabelle Luuk Asha and Will* kids from around the world who have been diagnosed with PH1. Having this rare genetic disease means that some of"
YouTube Link 2019-10-02T17:44Z [----] followers, [---] engagements

"Let's learn about RNAi (RNA interference) part [--] - How can proteins cause or contribute to disease This video is intended for U.S. audiences Video [--] of 3: Sometimes proteins your body makes can cause or contribute to disease. These proteins can be either be faulty or healthy. RNAi therapeutics are a type of medicine pioneered by Alnylam that treats disease by targeting and disabling specific mRNA (messenger RNA) which tell your body how to make these unwanted proteins. Science curious to learn more about the science of RNA interference (RNAi) Click here: https://bit.ly/3oR8r2l"
YouTube Link 2025-10-07T19:30Z [----] followers, [---] engagements

"Identifying Multiple Patient Archetypes with AHP This video was created for U.S. audiences. A panel of multidisciplinary physicians discuss the pathophysiology and clinical presentations of acute hepatic porphyria (AHP). Learn about the four types of AHP common symptoms and what happens during an AHP attack. Visit www.PorphyriaDiagnosis.com for more information. AS1-USA-00264"
YouTube Link 2020-11-23T22:47Z [----] followers, [---] engagements

"Glauciene (Brazil) Living with Acute Intermittent Porphyria (AIP) This video was created for U.S. audiences. Glauciene from Brazil lives with acute intermittent porphyria (AIP) a type of acute hepatic porphyria (AHP). In this video she discusses the pain associated with porphyria while reflecting on overcoming her adversities and how she lives with this rare disease. AHP refers to a family of rare genetic diseases characterized by potentially life-threatening attacks and for some patients chronic debilitating symptoms that negatively impact daily functioning and quality of life. In people"
YouTube Link 2021-10-27T23:08Z [----] followers, [----] engagements

"A Family Story of AHP This video was created for UK and Irish audiences. Featuring the story of a family living with AHP their journey perspective on genetic testing and living with a hereditary condition their information needs and how they feel about the future. NP-UK-00187"
YouTube Link 2023-03-24T16:36Z [----] followers, [----] engagements

"Alnylam Challengers Health Equity Symposium [----] As part of Alnylam Challengers we aim to connect entrepreneurs community partners and our employees to explore the challenges we collectively face and highlight inspiring solutions. We recently held one such event our first-ever Alnylam Challengers Health Equity Symposium at our headquarters in Cambridge MA. This event was open to community members industry partners and aspiring social entrepreneurs and was webcast to our employees around the globe. Hosted by Sara Nochur Alnylams Chief Diversity Officer it featured Amon Anderson Director of"
YouTube Link 2024-02-21T16:27Z [----] followers, [---] engagements

"Sophia's experience living with hATTR amyloidosis This video was created for audiences in the UK France Germany Portugal Spain and Sweden. Sophia talks about her diagnosis and experience living with hATTR amyloidosis and her desire to advocate for others NP-CEMEA-00247"
YouTube Link 2023-02-28T15:02Z [----] followers, [----] engagements

"Recognizing the Complexities of AHP This video was created for U.S. audiences. A panel of multidisciplinary physicians discuss the reasons why patients afflicted with acute hepatic porphyria (AHP) are often misdiagnosed or remain undiagnosed for up to [--] years. Learn about when they would consider suspecting testing for and diagnosing AHP. Visit www.PorphyriaDiagnosis.com for more information. AS1-USA-00266"
YouTube Link 2020-11-23T22:48Z [----] followers, [---] engagements

"Physiopathologie de la PHA La physiopathologie de la porphyrie comprend [--] troubles mtaboliques gntiques de la voie de biosynthse de l'hme. L'AHP un sous-type de porphyrie se manifeste souvent par une crise aigu soudaine ncessitant une hospitalisation et est dclenche par un excs d'ALA et de PBG. Regardez cette vido sur le mcanisme de la maladie pour approfondir vos connaissances sur la pathogense les signes et symptmes et le diagnostic de l'AHP. AS1-FRA-00049"
YouTube Link 2026-02-06T19:41Z [----] followers, [--] engagements

"Alnylam - RNAi RNAialnylam.jp CORP-JPN-00036 Alnylam Alnylam Pharmaceuticals RNAi RNAi Therapeutics Biotechnology siRNA Alnylam Alnylam Pharmaceuticals RNAi RNAi Therapeutics Biotechnology siRNA"
YouTube Link 2024-03-11T04:11Z [----] followers, [----] engagements

"Caregiving Perspectives: Anne and Candace Porphyria Learning to Give & Receive Care This video was created for U.S. audiences. Anne is a devoted mother and caregiver to her daughter Candace who has been living with acute hepatic porphyria (AHP) for more than [--] years. AHP refers to a family of rare genetic diseases characterized by potentially life-threatening attacks and for many patients chronic debilitating symptoms that negatively impact daily functioning and quality of life. Learn more: www.PinpointAHP.com AS1-USA-00010-102018 Alnylam ALNY $ALNY Genetic Condition Genetic Conditions Rare"
YouTube Link 2018-11-12T17:55Z [----] followers, [---] engagements

"Let's learn about RNAi (RNA interference) part [--] - How do RNAi Therapeutics treat disease #science This video is intended for U.S. audiences Video [--] of 3: Proteins are the "workers" in the biochemistry of life and are critical to almost everything your body does but sometimes they can also cause or contribute to disease. RNAi therapeutics which were pioneered by Alnylam work by preventing the production of specific unwanted proteins. They do this using a special kind of RNA called small interfering RNA (siRNA). Science curious to learn more about the science of RNAi Read more here:"
YouTube Link 2025-10-07T19:27Z [----] followers, [---] engagements

"Marc Living with Wild-Type ATTR Amyloidosis with Cardiomyopathy This video is intended for U.S. audiences. Marc and his wife Ruth share their experience with wild-type ATTR amyloidosis with cardiomyopathy including a misdiagnosis of hypertrophic cardiomyopathy. This is their experience and may not be reflective of how others present with this disease. NP-USA-00982 wild-type ATTR amyloidosis with cardiomyopathy ATTR amyloidosis cardiomyopathy Alnylam Alnylam pharma alnylam pharmaceuticals wtATTR wtATTR Amyloidosis wild-type ATTR amyloidosis with cardiomyopathy ATTR amyloidosis cardiomyopathy"
YouTube Link 2025-04-11T13:01Z [----] followers, [----] engagements

"The Coyle Family Story - Living with Hereditary ATTR (hATTR) amyloidosis This video is created for CEMEA audiences. Cousins James and Pat recall the story of their familys experience of hATTR amyloidosis including genetic testing and their hopes for the future of those diagnosed with the disease. NP CEMEA [-----] Alnylam Alnylam pharmaceuticals ALNY $Alny hATTR amyloidosis hereditary ATTR hATTR hereditary ATTR amyloidosis amyloidosis RNAi RNAi therapeutics rare disease rare diseases genetic disease genetic diseases Alnylam Alnylam pharmaceuticals ALNY $Alny hATTR amyloidosis hereditary ATTR"
YouTube Link 2022-06-03T22:13Z [----] followers, [----] engagements

"We Asked the Kids of Alnylam. During our [----] bring your kids to work day we asked the kids of Alnylam employees where their parent works and what do they do at Alnylam The answers are precious Learn more about what it's like to work at Alnylam at https://www.alnylam.com/careers/working-at-alnylam Alnylam Alnylam Pharmaceuticals Alnylam Alnylam Pharmaceuticals"
YouTube Link 2024-04-26T14:26Z [----] followers, [---] engagements

"Candace & Anne Living & Caregiving with Coproporphyria This video was created for U.S. audiences. Candace living with hereditary coproporphyria and her mother and caregiver Anne discuss how her porphyric pain and associated attacks have greatly impacted her life. Porphyrias are a family of rare genetic diseases characterized by potentially life-threatening attacks and for many patients chronic debilitating symptoms that negatively impact daily functioning and quality of life. Learn more: http://www.alnylam.com/patients/porphyria/ AS1-USA-00001-092018 Porphyria Acute Hepatic Porphyrias"
YouTube Link 2018-09-24T11:56Z [----] followers, [----] engagements

"2020: Extraordinary Year Extraordinary People [----] was an extraordinary year in many ways but none more so than the way that our employees rose to the challenges they and all of us faced. We are SO #AlnylamProud and look forward to what lies ahead in the new year If you're looking for new challenges in a new role we invite you to learn more about us and current career opportunities: http://bit.ly/2jOnA2v. #RNAitherapeutics #AlnylamCareers #RNAi #siRNA"
YouTube Link 2021-01-25T14:16Z [----] followers, [---] engagements

"From Possibility to Patients: The Eureka Moment In truly groundbreaking research there is often a moment of clarity a moment when you realize that your discovery has the potential to transform science and medicine as we know it. This is the Eureka moment on which Alnylam was built. Alnylam is leading the translation of RNAi into an entirely new innovative class of medicines. Learn more: http://www.alnylam.com/ alnylam pharmaceuticals rnai craig mello phillip sharp nobel prize medicine innovative discovery groundbreaking science cambridge biotech biopharmaceutical patients medical innovation"
YouTube Link 2016-10-03T13:20Z [----] followers, [----] engagements

"Celebrating [----] In November [----] we welcomed our 1000th employee and announced the opening of our offices in Canada and Brazil. alnylam alny $alny biotech alnylam alny $alny biotech"
YouTube Link 2018-11-19T14:51Z [----] followers, [---] engagements

"Alnylam Founders Day Event - June [--] [----] Alnylam employees and special guests gathered at MIT's Kresge Auditorium and remotely around the world for our Alnylam Founders Day Event part of the ongoing celebration of Alnylam's 20th anniversary. The program featured talks by leadership and a lively panel discussion with founders and others who were instrumental in Alnylam's birth and leadership of the #RNAiRevolution. Learn more about our 20th anniversary at https://www.alnylam20th.com/. #Alnylam20th #RNAi #RNAitherapeutics #siRNA #biotech Alnylam ALNY $ALNY RNAi RNAi therapeutics RNA"
YouTube Link 2022-06-02T13:43Z [----] followers, [---] engagements

"Alnylam Community Service Week [----] As part of our Global Community Service Week Alnylam employees in the US and Europe came together (many for the first time since the pandemic began) and fanned out across the communities in which we live and work to clear brush harvest produce clean make meals assemble science kits and much more working with more than [--] community organizations. Our ongoing Helping Hands: Alnylam Volunteers program harnesses and nurtures the passion of our people and their desire to put good into the world supporting both company-organized and employee-driven #volunteerism."
YouTube Link 2021-10-08T14:11Z [----] followers, [---] engagements

"Pathophysiology of Acute Hepatic Porphyria (AHP) This video was created for CEMEA audiences. The pathophysiology of porphyria comprises [--] genetic metabolic disorders of the heme biosynthesis pathway. AHP a subset of porphyria often presents as a sudden acute attack requiring hospitalization and is triggered by excess ALA and PBG. Watch this Mechanism of Disease video to take a deeper look at the pathogenesis signs and symptoms and diagnosis of AHP. NP-INTR-00049"
YouTube Link 2024-02-13T14:03Z [----] followers, [----] engagements

"Lets learn about RNAi (RNA interference) part [--] - What is an RNAi Therapeutic #rnai #science This video is intended for U.S. audiences Video [--] of 3: RNA interference (RNAi) is a naturally occurring process of gene regulation that is already at work inside your body. RNAi therapeutics which were pioneered by Alnylam utilize this process to silence the genes that cause or contribute to disease. Science curious to learn more about RNAi Click here: https://bit.ly/3oR8r2l"
YouTube Link 2025-10-07T19:00Z [----] followers, [---] engagements

"John Maraganore on the ORION-11 Phase [--] Results On 9/2/19 our partner The Medicines Company presented the results of the ORION-11 Phase [--] clinical trial of inclisiran our investigational RNAi therapeutic for the treatment of hypercholesterolemia at the European Society of Cardiology meeting. These results represent a landmark event with significant implications for Alnylam and RNAi therapeutics. Our CEO John Maraganore Ph.D. shares his thoughts in this video. You can also read more here: http://bit.ly/34jxFLh Alnylam ALNY $ALNY RNAi RNAi therapeutics inclisiran hyper hypercholesterolemia John"
YouTube Link 2019-09-02T06:58Z [----] followers, [---] engagements

"PH1 of a Kind: Will's Story - Learning to be Confident This video was created for U.S. audiences. Watch as Will from Australia is encouraged by his best friend Oliver to be confident and tell others about his PH1 and they come to realize that in most ways Will is just like them. Primary hyperoxaluria type [--] (PH1) is a rare genetic disease. PH1 of a Kind has been developed in partnership with the Oxalosis & Hyperoxaluria Foundation. PH1 of a Kind is a 4-part video series starring Isabelle Luuk Asha and Will* kids from around the world who have been diagnosed with PH1. Having this rare genetic"
YouTube Link 2019-12-03T16:11Z [----] followers, [---] engagements

"hATTR Tipping Point - Rick (U.S.) This video was created for US audiences. Meet Rick living with hereditary transthyretin-mediated (hATTR) amyloidosis. When Ricks symptoms began to pile up he thought it might have been due to old age. However Rick reached his tipping point when his symptoms got worse. His brother recommended that Rick get tested for hATTR amyloidosis which led to the right diagnosis. Learn more about Ricks story and hATTR amyloidosis at http://www.hATTRbridge.com. TTR02-USA-00764 Alnylam Alnylam pharmaceuticals ALNY $Alny hATTR amyloidosis hereditary ATTR hATTR hereditary"
YouTube Link 2022-05-06T16:21Z [----] followers, [---] engagements

"Alnylam & RNAi Therapeutics: Silencing Disease. Amplifying Life. This video is intended for U.S. audiences Living with disease is noisy. The day-to-day of life is filled with unpleasant and unwanted sounds that over time mute the joy of life. But when RNAi therapeutics a type of medicine pioneered by Alnylam silence the genes that cause or contribute to disease the everyday joys of life can be amplified. Learn more at www.silencedisease.com ALNYCC2025-M1.1 Alnylam Alnylam Pharmaceuticals RNAi RNAi Therapeutics RNA Interference Gene Silencing Silence Disease Amplify Life Alnylam Alnylam"
YouTube Link 2025-04-01T13:47Z [----] followers, [----] engagements

"Boston Globe Top Places to Work [----] We're proud to be named a Boston Globe Top Places to Work for [----]. This marks our third consecutive year on the list. Learn more about what makes us a great place to work and see current job openings at http://www.alnylam.com/careers/ alnylam ALNY $ALNY biotech biotech jobs pharma jobs biotech careers alnylam ALNY $ALNY biotech biotech jobs pharma jobs biotech careers"
YouTube Link 2017-11-17T16:11Z [----] followers, [---] engagements

"How Can Unwanted Proteins Cause or Contribute to Disease This video is intended for U.S. audiences Video [--] of 3: Sometimes proteins your body makes can cause or contribute to disease. These proteins can be either be faulty or healthy. RNAi therapeutics are a type of medicine pioneered by Alnylam that treats disease by targeting and disabling specific mRNA (messenger RNA) which tell your body how to make these unwanted proteins. Science curious to learn more about the science of RNAi Click here: https://bit.ly/3oR8r2l Other videos in this series: Video 1: https://bit.ly/4dEgHe8 Video 2:"
YouTube Link 2024-08-28T19:44Z [----] followers, [---] engagements

"Alnylam [----] Corporate Responsibility Report Highlights. This video is intended for U.S. audiences. Our [----] Corporate Responsibility Report highlights how Alnylam is making an impact. From supporting patients and employees to advancing science uplifting communities and protecting the planet our work reflects our values and our ambition to give back to society. Learn more and read the full report at https://www.alnylam.com/about-alnylam/corporate-responsibility #corporateresponsibility #CSR #biotechnology Alnylam Alnylam"
YouTube Link 2025-07-24T15:01Z [----] followers, [---] engagements

"Who We Are: Alnylam's Core Values Our core values represent the heart of Alnylam's culture and how we work together to serve the best interests of patients and our communities. Watch this video to hear employees explain what our core values - Commitment to People Innovation & Discovery Sense of Urgency Open Culture and Passion for Excellence - mean to them and all of us. Want to learn more about our careers and our culture Visit http://www.alnylam.com/careers/"
YouTube Link 2023-11-02T15:00Z [----] followers, [----] engagements

"Caregiver Perspectives: The Cataldo Family Primary Hyperoxaluria Type [--] (PH1) This video was created for U.S. audiences. The Cataldo family - mother Pat and brother Matthew discuss caregiving for John who was diagnosed with primary hyperoxaluria type [--] (PH1) at age [--] and at age [--] went into kidney failure. PH1 is an ultra-rare life-threatening disease that can cause irreparable damage to kidneys and other vital organs. Learn more about PH1 here: http://www.alnylam.com/patients/prima. GO1-USA-00035 primary hyperoxaluria primary hyperoxaluria type [--] PH1 rare disease rare diseases genetic"
YouTube Link 2019-11-07T03:17Z [----] followers, [---] engagements

"Alnylam Accepted the Red Tie Challenge Alnylam accepted the Red Tie Challenge in honor of Bleeding Disorders Awareness Month Our team stands unified with patients living with hemophilia and other rare bleeding disorders. alnylam nhf red tie challenge hemophilia bleeding disorders bleeding disorders awareness month bdam alnylam pharmaceuticals alnylam nhf red tie challenge hemophilia bleeding disorders bleeding disorders awareness month bdam alnylam pharmaceuticals"
YouTube Link 2017-03-28T14:32Z [----] followers, [---] engagements

"The Dreamers - Developing a New Class of Medicines The Dreamers are the ones who realized the discovery of RNAi had the potential to transform the way we treat disease. They were steadfast in their belief of the raw science even in the face of great potential failure for the chance to develop new treatments for many patients. This was the origin of RNAi therapeutics a potential new class of medicines. Learn more at https://newclassofmedicines.com/ This is the first video in a four part series which is being released in installments over the coming months. Each represents a stage in the"
YouTube Link 2018-04-04T19:12Z [----] followers, [----] engagements

"Caregiving Perspectives: Natalie & Jared Primary Hyperoxaluria Type [--] (PH1) This video was created for U.S. audiences. Natalie and Jared who have three children living with primary hyperoxaluria type [--] (PH1) talk about their roles as caregivers. PH1 is an ultra-rare life-threatening disease that can cause irreparable damage to kidneys and other vital organs. Learn more about PH1 here: http://www.alnylam.com/patients/primary-hyperoxaluria/ GO1-USA-00001-102018 Alnylam ALNY $ALNY Raredisease Rarediseases PH1 primary hyperoxaluria primary hyperoxauria type [--] genetic disease genetic diseases"
YouTube Link 2018-11-12T14:54Z [----] followers, [---] engagements

"The Believers - Developing a New Class of Medicines The Believers are those who put their faith in the promise of RNAi therapeutics through times of optimism and times of uncertainty. They understood that what Alnylam was seeking to do was hard and would take time but they believed that this new class of medicines had the potential to have a significant impact on the lives of patients. Learn more at newclassofmedicines.com This is the third video in a four part series which is being released in installments over the coming months. Each represents a stage in the journey to develop RNAi"
YouTube Link 2018-06-01T18:36Z [----] followers, [----] engagements

"International Porphyria Awareness Week PAG Perspectives: Around the Globe This video was created for US audiences. Patient advocacy group leaders from around the globe discuss the importance of raising awareness of porphyria a rare often genetic disease and how the community can get involved in International Porphyria Awareness Week. For more information on porphyria visit https://www.gpac-porphyria.org/ AS1-USA-00971 Alnylam Alnylam Pharmaceuticals Alnylam Pharma ALNY $ALNY Rare disease rare diseases genetic diease genetic diseases AHP Porphyria Acute Hepatic Porphyria IPAW IPAW2021"
YouTube Link 2021-04-02T17:46Z [----] followers, [---] engagements

"Caregiver Perspectives: The Wallenberg Family Primary Hyperoxaluria Type [--] (PH1) This video was created for U.S. audiences. The following video represents the experience of a family impacted by primary hyperoxaluria type [--] (PH1) and may not be reflective of how other families may cope with caring for someone diagnosed with this rare condition. Dan and Laura talk about caregiving for their 6-year old daughter EV who was diagnosed with primary hyperoxaluria type [--] (PH1) as an infant. PH1 is a rare life-threatening disease that can cause irreparable damage to kidneys and other organs. To learn"
YouTube Link 2020-10-22T21:41Z [----] followers, [---] engagements

"hATTR Tipping Point - Dr. Champion This video was created for US audiences. Meet Dr. Champion who manages patients living with hereditary transthyretin-mediated (hATTR) amyloidosis a rare disease which affects people differently and can be difficult to diagnose as its symptoms can resemble those of other conditions. In this video see some of the tipping point moments that lead Dr. Champion to suspect hATTR amyloidosis in his patients. Learn more at http://www.hATTRbridge.com. TTR-USA-00012 Alnylam Alnylam pharmaceuticals ALNY $Alny hATTR amyloidosis hereditary ATTR hATTR hereditary ATTR"
YouTube Link 2022-05-10T20:09Z [----] followers, [---] engagements

"International Porphyria Awareness Week PAG Perspectives: Germany This video was created for US audiences. Dr. Thorsten Schweikardt from Selbsthilfe EPP e.V. and Sabine von Wegerer from Berliner Leberring e.V discuss the importance of raising awareness of porphyria a rare often genetic disease and how the community can get involved in International Porphyria Awareness Week. For more information on porphyria visit https://www.gpac-porphyria.org/ AS1-USA-00968 Alnylam Alnylam Pharmaceuticals Alnylam Pharma ALNY $ALNY Rare disease rare diseases genetic diease genetic diseases AHP Porphyria Acute"
YouTube Link 2021-04-02T17:46Z [----] followers, [---] engagements

"What is an RNAi Therapeutic This video is intended for U.S. audiences Video [--] of 3: RNA interference (RNAi) is a naturally occurring process of gene regulation that is already at work inside your body. RNAi therapeutics which were pioneered by Alnylam utilize this process to silence the genes that cause or contribute to disease. Science curious to learn more about RNAi Click here: https://bit.ly/3oR8r2l Other videos in this series: Video 2: https://bit.ly/4dGhkDI Video 3: https://bit.ly/3X6aPmz #RNAinterference #RNAi #RNAiTherapeutics #siRNA #GeneSilencing #rnai ALNCORP6.24 RNA interference"
YouTube Link 2024-08-28T19:31Z [----] followers, [----] engagements

"PH1 of a Kind - Isabelles Story: Learning About PH1 This video was created for US audiences. Watch as Isabelle from the U.S. and her elementary school classmates learn about how the kidneys and liver work and Isabelle shares what its like to live with PH1 (primary hyperoxaluria type 1) a rare genetic disease. PH1 of a Kind has been developed in partnership with the Oxalosis & Hyperoxaluria Foundation. PH1 of a Kind is a 4-part video series starring Isabelle Luuk Asha and Will* kids from around the world who have been diagnosed with PH1. Having this rare genetic disease means that some of"
YouTube Link 2019-09-06T13:18Z [----] followers, [----] engagements

"hATTR Tipping Point - Cece (U.S.) This video was created for US audiences. Meet CeCe living with hereditary transthyretin-mediated (hATTR) amyloidosis. As CeCe worked with her doctors to find an answer for her unexplained symptoms she continued to be misdiagnosed with other conditions. Eventually CeCe reached her tipping point. She finally received the right diagnosis after she found a doctor who put the pieces together and tested for hATTR amyloidosis. Learn more about CeCes story and hATTR amyloidosis at http://www.hATTRbridge.com. TTR02-USA-00765 Alnylam Alnylam pharmaceuticals ALNY $Alny"
YouTube Link 2022-05-06T16:22Z [----] followers, [---] engagements

"Alistair et Lesley (Canada)- Vivre avec lhATTR Cette vido a t cre pour le public canadien. Alistair est atteint damylose hrditaire ATTR (hATTR). Lui et sa femme Lesley parlent de leur vie avec lamylose hATTR et de leurs espoirs pour lavenir. TTR02-CAN-00088 Alnylam alnylam pharmaceuticals ALNY $ALNY genetic disease genetic diseases rare disease rare diseases hATTR ATTR TTR hereditary ATTR amyloidosis amyloidosis damylose hrditaire ATTR damylose Alnylam alnylam pharmaceuticals ALNY $ALNY genetic disease genetic diseases rare disease rare diseases hATTR ATTR TTR hereditary ATTR amyloidosis"
YouTube Link 2020-12-10T21:11Z [----] followers, [--] engagements

"Caregiving Their Own Way: Meet Keili - Wife & Caregiver This video was created for U.S. audiences. Keili discusses her experience caregiving for her husband Colin who is living with acute hepatic porphyria (AHP). AHP refers to a family of rare genetic diseases characterized by potentially life-threatening attacks and for many patients chronic debilitating symptoms that negatively impact daily functioning and quality of life. Learn more: www.PinpointAHP.com Corp-USA-00002-112017 Porphyria Porphyrias Acute Hepatic Porphyria Caregiving Caregiver Caregivers Rare Disease Rare Diseases Porphyria"
YouTube Link 2017-11-16T00:45Z [----] followers, [---] engagements

"The Futurists - Developing a New Class of Medicines Bringing the first of a new class of medicines to market was only the beginning of RNAis journey. Building on Alnylams pioneering work the Futurists are identifying new targets for RNAi therapeutics beyond the liver and orphan diseases to expand the role that RNAi-based medicines can play in treating human disease. This is the seventh video in a seven part series which is being released in installments over the coming months. Each represents a stage in the journey to develop RNAi therapeutics and in them youll meet the dreamers pioneers"
YouTube Link 2020-08-07T13:56Z [----] followers, [---] engagements

"The Pioneers - Developing a New Class of Medicines The Pioneers are those whose picked up the mantle from the Dreamers and shaped the vision for what RNAi could mean for medicine. With Alnylam since the beginning their work laid the foundation that is turning the hope of RNAi therapeutics a potential new class of medicines into reality. Learn more at newclassofmedicines.com This is the second video in a four part series which is being released in installments over the coming months. Each represents a stage in the journey to develop RNAi therapeutics and in them youll meet the dreamers"
YouTube Link 2018-05-03T20:10Z [----] followers, [---] engagements

"Trailer: PBS Medical Stories PH1 Documentary This video is intended for US audiences. Watch this trailer to an upcoming PBS/Medical Stories Documentary about the journey of an amazing family impacted by a rare metabolic disease - primary hyperoxaluria type [--] or PH1. Learn about the devastating effects of PH1 and the children in this family two of whom have had to undergo kidney and liver transplantation as a result of this inherited disease that is often characterized by progressive kidney failure. PH1-USA-00073 primary hyperoxaluria type [--] hyperoxaluria kidney disease kidney failure rare"
YouTube Link 2022-03-30T13:00Z [----] followers, [---] engagements

"A Family Story of AHP This video was created for US and UK audiences. Featuring the story of a family living with AHP their journey perspective on genetic testing and living with a hereditary condition their information needs and how they feel about the future. AS1-USA-01486"
YouTube Link 2023-04-18T18:09Z [----] followers, [----] engagements

"Lernen Sie Alnylam kennen - ein fhrendes Unternehmen in RNAi-Therapeutika Dieses Video wurde fr ein deutschsprachiges Publikum erstellt. Alnylam ist ein Pionier auf dem Gebiet der RNAi-Therapeutika (RNAi RNA-Interferenz) - einer innovativen Klasse von Medikamenten die hochspezifisch die Bildung krankheitsverursachender Proteine verhindern kann. Wir sind ein globales und schnell wachsendes biopharmazeutisches Unternehmen das sich zum Ziel gesetzt hat das Leben von Menschen auf der ganzen Welt positiv zu verndern - sowohl durch unsere Medikamente als auch durch Engagement. Wir laden Sie ein"
YouTube Link 2024-05-06T11:37Z [----] followers, [----] engagements

"The Collaborators - Developing a New Class of Medicines The Collaborators are working to ensure that people around the world who may benefit from innovative RNAi therapeutics have access to them. These collaborators include Alnylam employees as well as payers regulators and government employees. Through Alnylam's Patient Access Philosophy and innovative pricing agreements such as Value Based Agreements Alnylam is working to be as innovative in the way that we commercialize our medicines as we are in developing them. This is the sixth video in a seven part series which is being released in"
YouTube Link 2019-12-12T20:52Z [----] followers, [---] engagements

"Alnylam Assist - Our Patient Services Program for U.S. Residents This video was created for U.S. audiences. Learn about the services available to U.S. patients and their caregivers through the Alnylam Assist - Alnylam's patient services program. Get more information at AlnylamAssist.com or call 1-833-256-2748. Individuals must meet specified eligibility criteria including financial eligibility criteria to qualify for assistance. Alnylam reserves the right to make eligibility determinations and to modify or discontinue the program at any time. TTR02-USA-00026-012019 Alnylam Alnylam"
YouTube Link 2021-02-18T19:13Z [----] followers, [---] engagements

"Who We Are: Alnylam's Core Values Our core values represent the heart of Alnylam's culture and how we work together to serve the best interests of patients and our communities. Watch this video to hear employees explain what our core values - Commitment to People Innovation & Discovery Sense of Urgency Open Culture and Passion for Excellence - mean to them and all of us. We invite you to learn more about our careers and our culture at http://www.alnylam.com/careers/ Alnylam ALNY $ALNY RNAi Therapeutics RNAi RNA interference Gene silencing RNAi medicines Careers Culture Careers and Culture"
YouTube Link 2022-03-16T17:13Z [----] followers, [----] engagements

"The Makers - Developing a New Class of Medicines The Makers are the ones charged with manufacturing RNAi therapeutics. Since RNAi therapeutics are a new class of medicines there was no set of blueprints to follow but rather the Makers needed to devise solutions for manufacturing quality control and supply chain that were new to both Alnylam and the pharmaceutical industry. This is the fifth video in a seven part series which is being released in installments over the coming months. Each represents a stage in the journey to develop RNAi therapeutics and in them youll meet the dreamers pioneers"
YouTube Link 2019-10-03T19:27Z [----] followers, [----] engagements

"Alnylam: What's in a Name Our name may not be the easiest to pronounce but once you learn it you never forget it. Alnilam is the Arabic word for string of pearls and is also the center star in Orions belt shining the brightest of them all. Both are fitting with our mission to build a top-tier biopharmaceutical company and to make the future brighter for patients. alnylam motion graphic orion orion's belt alnilam biopharmaceutical rnai rnai therapeutics alnylam motion graphic orion orion's belt alnilam biopharmaceutical rnai rnai therapeutics"
YouTube Link 2016-10-03T13:20Z [----] followers, [----] engagements

"Alnylam Challengers - A Community Impact Program to Improve Health Access in Underserved Communities Alnylam Challengers is a health equity-focused community impact program that supports bold and diverse organizations in their pursuit of developing new and sustainable solutions to address challenges in healthcare access. Through this program Alnylam collaborates with social entrepreneurs employees and business partners to create innovative health solutions to tackle obstacles to accessing health care such as poverty racial discrimination and other social determinants of health. Alnylams first"
YouTube Link 2021-10-13T12:57Z [----] followers, [----] engagements

"The Importance of Genetic Testing This video was created for UK and Irish audiences. Siblings living with hATTR in Canada Dan and Diana talk about their journey to diagnosis the importance of genetic testing and their support for each other. NP-UK-00189"
YouTube Link 2023-03-24T16:37Z [----] followers, [----] engagements

"Trailer - Developing a New Class of Medicines From the Eureka moment in [----] of the discovery of RNA interference to today when investigational RNAi therapeutics are on the verge of becoming a new class of medicines the journey has hinged on the passion and persistence of hundreds of people. This is the trailer for a four part series which will be released in installments over the coming months. Each represents a stage in the journey to develop RNAi therapeutics and in them youll meet the dreamers pioneers and believers whos confidence in the potential of therapeutic value of RNAi has been"
YouTube Link 2018-02-28T13:18Z [----] followers, [----] engagements

"Alnylam-Sponsored PBS Medical Stories - PH1: Bonded Hope This film is intended for US audiences. This documentary tells the story of an amazing family with four children three of whom are impacted by a rare metabolic disease - primary hyperoxaluria type [--] or PH1. Learn about the devastating consequences of PH1 and how for some this genetic disease means having to have a kidney and liver transplantation as a result of an underlying liver defect and severe damage to the kidneys that is typical for patients diagnosed with this progressive disease. PH1-USA-00185"
YouTube Link 2023-08-07T14:40Z [----] followers, [----] engagements

"The Skinner Family - Living with Primary Hyperoxaluria Type [--] (PH1) This video was created for U.S. audiences. Three of the four Skinner children have been diagnosed with PH1 a rare life-threatening disease that can cause irreparable damage to kidneys and other vital organs. Learn more about PH1 here: https://www.alnylam.com/patients/primary-hyperoxaluria/ GO1-USA-00260 alnylam alny $alny rare disease rare diseases genetic disease genetic diseases PH1 primary hyperoxaluria hyperoxaluria primary hyperoxaluria type [--] oxalate oxalate buildup alnylam alny $alny rare disease rare diseases genetic"
YouTube Link 2020-08-18T19:26Z [----] followers, [----] engagements

"Helping Hands - Community Service Day [----] Alnylam employees invested more than [----] hours of service to local organizations during our 3rd annual Helping Hands Community Service Day. Our CSD is an important part of our commitment to our people and the communities in which we work and live. Learn more about our culture at http://www.alnylam.com/careers/our-culture/ Community Service Boston Zug Switzerland Giving Back Community Service Boston Zug Switzerland Giving Back"
YouTube Link 2017-06-28T13:40Z [----] followers, [---] engagements

"How do RNAi Therapeutics Treat Disease This video is intended for U.S. audiences Video [--] of 3: Proteins are the "workers" in the biochemistry of life and are critical to almost everything your body does but sometimes they can also cause or contribute to disease. RNAi therapeutics which were pioneered by Alnylam work by preventing the production of specific unwanted proteins. Science curious to learn more about the science of RNAi Read more here: https://bit.ly/3oR8r2l Other videos in this series: Video 1: https://bit.ly/4dEgHe8 Video 3: https://bit.ly/3X6aPmz #RNAiTherapeutics #RNAi"
YouTube Link 2024-08-28T19:39Z [----] followers, [----] engagements

"From Possibility to Patients: The Eureka Moment (UK) This video was intended for UK and Ireland audiences. In truly groundbreaking research there is often a moment of clarity a moment when you realize that your discovery has the potential to transform science and medicine as we know it. This is the Eureka moment on which Alnylam was built. Alnylam is leading the translation of RNAi into an entirely new innovative class of medicines. Learn more: http://www.alnylam.com/ NP-UK-0062 alnylam pharmaceuticals rnai craig mello phillip sharp nobel prize medicine innovative discovery groundbreaking"
YouTube Link 2021-10-27T22:20Z [----] followers, [---] engagements

"The Coyle Family Story - Living with Hereditary ATTR (hATTR) amyloidosis This video was created for audiences in the UK & Ireland. Cousins James and Pat recall the story of their familys experience of hATTR amyloidosis including genetic testing and their hopes for the future of those diagnosed with the disease. NP IRL [-----] Alnylam Alnylam pharmaceuticals ALNY $Alny hATTR amyloidosis hereditary ATTR hATTR hereditary ATTR amyloidosis amyloidosis RNAi RNAi therapeutics rare disease rare diseases genetic disease genetic diseases Alnylam Alnylam pharmaceuticals ALNY $Alny hATTR amyloidosis"
YouTube Link 2022-06-03T22:13Z [----] followers, [---] engagements

"Caregiver Perspectives: Caring for Someone with Acute Hepatic Porphyria (AHP) This video was created for U.S. audiences. Three families talk about the impact of AHP on their lives and what its like to care for someone living with this rare disease. Porphyria is a family of rare genetic diseases characterized by potentially life-threatening attacks and for some patients chronic debilitating symptoms that negatively impact daily functioning and quality of life. Porphyria includes eight subtypes and each has unique manifestations making an accurate diagnosis even more challenging. Four of these"
YouTube Link 2019-11-07T04:32Z [----] followers, [----] engagements

"From Possibility to Patients: The Scientific Odyssey - The Dark Ages Alnylam faced many challenges in its early history. The dissolution of major partnerships led to turmoil and a loss of faith in the technology outside the walls of Alnylam. Within the company there remained an unwavering belief a continued focus and enthusiasm and drive to make RNAi therapeutics a reality. Alnylam is leading the translation of RNAi into an entirely new innovative class of medicines. Learn more: http://www.alnylam.com/ alnylam biopharmaceutical biotechnology rnai therapeutic patients solving delivery liver"
YouTube Link 2016-10-03T13:19Z [----] followers, [----] engagements

"6x in a Row Alnylam Named a Boston Globe Top Place to Work for [----] For the sixth year in a row Alnylam has been named to The Boston Globe's Top Places to Work list. We ranked 15th in the [----] "Large Employer" category and are the highest ranked biopharmacutical company on this year's list. Top Places to Work rankings reflect the voice of employees at the companies at which they work. Between April and June [----] employees were able to complete a 24-question survey which asked them to evaluate their companys leadership communication values benefits working environment and more. Learn more"
YouTube Link 2020-11-20T16:34Z [----] followers, [---] engagements

"International Porphyria Awareness Week PAG Perspectives: Mexico This video was created for US audiences. Kika Shabot from the Sociedad Mexicana para Porfiria discusses the importance of raising awareness of porphyria a rare often genetic disease and how the community can get involved in International Porphyria Awareness Week. For more information on porphyria visit https://www.gpac-porphyria.org/ AS1-USA-00969 Alnylam Alnylam Pharmaceuticals Alnylam Pharma ALNY $ALNY Rare disease rare diseases genetic diease genetic diseases AHP Porphyria Acute Hepatic Porphyria IPAW IPAW2021 International"
YouTube Link 2021-04-02T17:46Z [----] followers, [---] engagements

"The Heroes - Developing a New Class of Medicines The Heroes are the brave people living with devastating diseases and the people who are dedicated to helping them. Theyre the first to embrace the promiseand the hopeof a potential new class of medicines. Learn more at newclassofmedicines.com This is the fourth video in a four part series which is being released in installments over the coming months. Each represents a stage in the journey to develop RNAi therapeutics and in them youll meet the dreamers pioneers and believers whos confidence in the potential of therapeutic value of RNAi has"
YouTube Link 2018-06-22T16:28Z [----] followers, [---] engagements

"From Possibility to Patients: The Scientific Odyssey - The Slope of Enlightenment After overcoming seemingly insurmountable hurdles Alnylam has built an R&D engine and product pipeline with the potential to address a broad spectrum of diseases. Today Alnylam is dedicated to proving that innovative science perseverance and passion can come together to improve the lives of patients. Alnylam is leading the translation of RNAi into an entirely new innovative class of medicines. Learn more: http://www.alnylam.com/ alnylam rnai therapeutics patients hattr biotechnology biopharmaceutical rnai rnai"
YouTube Link 2016-10-03T13:19Z [----] followers, [----] engagements

"The Cataldo Family - John's Diagnosis Dialysis and Transplant Story This video was created for US audiences. John a liver/kidney transplant recipient discusses his journey with primary hyperoxaluria type [--] (PH1). John was diagnosed with PH1 at age [--] and went into kidney failure at age [--]. Click here to learn more: https://www.alnylam.com/patients/primary-hyperoxaluria/ GO1-USA-00039 primary hyperoxaluria primary hyperoxaluria type [--] rare disease rare diseases genetic disease genetic diseases kidney failure end stage renal disease alnylam alnylam pharmaceuticals ALNY rnai rnai therapeutics"
YouTube Link 2020-08-07T15:11Z [----] followers, [---] engagements

"Alnylam Celebrates Rare Disease Day [----] Even though we couldn't be together for #RareDiseaseDay this year we're so #AnylamProud of how our employees around the world came together to show their support for the #RareDisease community It's truly reflective of the passion they show for helping people living with #RareDiseases EVERY day. About our photos: this year because this is a year like no other we virtually lit up buildings and landmarks across the globe where Alnylam has operations to #LightUpForRare. Our employees have been sharing their photos on their personal social media channels"
YouTube Link 2021-03-01T14:38Z [----] followers, [---] engagements

"Johan lever med AHP This video is intended for CEMEA audiences. "Nr man har en akut attack av porfyri s har man s oerhrt ont i hela magregionen och brstkorgen. Det r svrt att beskriva den smrtan och att inte bli trodd i det. Man knner sig s otroligt maktls. S fr mig r det oerhrt viktigt att vrdpersonal frstr vad det handlar om s att man snabbt kan f rtt hjlp." AS1-CEMEA-00217 Alnylam Alnylam pharma alnylam pharmaceuticals ALNY $ALNY Porphyria Acute Hepatic Porphyria AHP genetic disease genetic diseases rare disease rare diseases Akut hepatisk porfyri porfyri Alnylam Alnylam pharma alnylam"
YouTube Link 2021-06-16T23:00Z [----] followers, [---] engagements

"Conhea Alnylam - O Lder em Teraputica RNAi A Alnylam foi pioneira na teraputica de RNAi (interferncia de RNA) - uma classe inovadora de medicamentos que silencia os genes que causam ou contribuem para doenas. Somos uma empresa biofarmacutica global e de rpido crescimento motivada para ter um impacto positivo na vida das pessoas em todo o mundo tanto com os nossos medicamentos como com as nossas aes fora do laboratrio. Convidamos voc a saber mais em alnylam.com.br CORP-BRA-00035 Alnylam ALNY Alnylam Pharma Alnylam pharmaceuticals Leader in RNAi RNAi therapeutics Alnylam ALNY Alnylam Pharma"
YouTube Link 2024-11-11T17:28Z [----] followers, [---] engagements

"From Possibility to Patients: The Scientific Odyssey - The RNAi Boom There was a time when interest in RNAi boomed. Everyone wanted a piece of it. Excitement for this promising new approach to treating disease drew in multiple pharmaceutical players millions of dollars and ambition to be the first to unlock the power of this new discovery. alnylam scientific odyssey rnai therapeutics pharmaceutical biopharmaceutical biotechnology innovation protein production hattr alnylam scientific odyssey rnai therapeutics pharmaceutical biopharmaceutical biotechnology innovation protein production hattr"
YouTube Link 2016-10-03T13:19Z [----] followers, [----] engagements

"RNAi una prometedora plataforma para el desarrollo de frmacos Este vdeo ha sido creado para el pblico espaol. This video was created for Spanish audiences. La interferencia de ARN (ARNi) es un avance en la comprensin de cmo se regulan los genes en las clulas. Tambin representa un enfoque completamente nuevo para el descubrimiento y desarrollo de frmacos. El Premio Nobel de Fisiologa y Medicina [----] otorgado a Craig Mello y Andrew Fire reconoci la importancia del RNAi como un descubrimiento cientfico importante. Alnylam lidera la traduccin de RNAi en una clase completamente nueva de"
YouTube Link 2025-11-10T14:00Z [----] followers, [---] engagements

"Caregiver Perspectives: Jackie and Colin Primary Hyperoxaluria Type [--] (PH1) This video was created for CEMEA audiences. As a newborn Ziggy was diagnosed with primary hyperoxaluria type [--] (PH1)a rare inherited disease that causes the overproduction of oxalate which builds up as crystals throughout the body. Watch Ziggys parents Jackie and Colin discuss their familys experience navigating life with PH1. NP-INTX-00176 Alnylam Alnylam pharma alnylam pharmaceuticals PH1 primary hyperoxaluria primary hyperoxaluria type [--] patient story patient journey with ph1 caregiver caregiver story PH1 caregiver"
YouTube Link 2025-04-17T17:53Z [----] followers, [---] engagements

"Dcouvrez Alnylam Leader dans le dveloppement des ARNi thrapeutiques Cette video est destine au public franais. Alnylam est un leader du dveloppement des ARNi (ARN interfrents) thrapeutiques une nouvelle classe de mdicaments innovants permettant de silencer des gnes lorigine dune pathologie ou contribuant cette dernire. Apprenez-en davantage sur alnylam.fr NP-FRA-00448 Alnylam Alnylam Pharmaceuticals RNAi RNAi Therapeutics Biotechnology siRNA Alnylam Alnylam Pharmaceuticals RNAi RNAi Therapeutics Biotechnology siRNA"
YouTube Link 2024-12-11T17:27Z [----] followers, [---] engagements

"Sue - Living with Acute Hepatic Porphyria (AHP) This video was created for CEMEA audiences. Acute Hepatic Porphyria (AHP) is a chronic disease that can place a heavy burden on the lives of patients and their loved ones. Hear from Sue how she was diagnosed with acute hepatic porphyria how she copes with it and how it affects her daily live. "Im advocating to try and make sure theres a lot of awareness disease awareness. To make sure that my little girl doesnt suffer in the same way that me and my sister have. Because no one should suffer in the way that we have." AS1-INTR-00020 Alnylam alnylam"
YouTube Link 2024-10-21T15:51Z [----] followers, [---] engagements

"RNAi vielversprechendes Potenzial fr eine neue Klasse von Medikamenten Dieses Video wurde fr ein deutsches Publikum erstellt. Die RNA-Interferenz (RNAi) ist ein Durchbruch beim Verstndnis wie Gene in Zellen reguliert werden. Es stellt auch einen vllig neuen Ansatz in der Wirkstoffforschung und -Entwicklung dar. Der Nobelpreis fr Physiologie oder Medizin [----] der an Craig Mello und Andrew Fire verliehen wurde wrdigte die Bedeutung von RNAi als eine wichtige wissenschaftliche Entdeckung. Alnylam ist fhrend bei der Umsetzung von RNAi in eine vllig neue Klasse innovativer Medikamente. Erfahren"
YouTube Link 2024-06-25T18:19Z [----] followers, [----] engagements

"RNAi "RNA interference (RNAi)1 RNAiRNAiAlnylam()RNAismall interfering RNA(siRNA)RNAiRNA(mRNA) https://www.alnylam.jp/our-science"
YouTube Link 2023-03-23T13:54Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing